Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,7126 USD | +1,80% |
|
-9,56% | -77,87% |
18/06 | OVID THERAPEUTICS INC. : Oppenheimer is niet langer positief gestemd | ZM |
18/06 | OVID THERAPEUTICS INC. : B. Riley geeft koopadvies | ZM |
Vakgebied
Aantal werknemers: 40
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100,0
%
| 2 | 100,0 % | 0 | 100,0 % | -73,93% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 0 | 100,0 % | -73,93% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jeremy Levin
CEO | Chief Executive Officer | 70 | 01-04-14 |
Jeffrey Rona
DFI | Director of Finance/CFO | 55 | 01-01-19 |
Zhong Zhong
CTO | Chief Tech/Sci/R&D Officer | - | 28-06-23 |
Manoj Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 08-02-23 |
Jason Tardio
COO | Chief Operating Officer | 47 | 18-11-19 |
Julia Tsai
CTO | Chief Tech/Sci/R&D Officer | - | 08-07-21 |
Thomas Perone
CMP | Compliance Officer | 59 | 21-03-19 |
Toshiya Nishi
PRN | Corporate Officer/Principal | - | 08-02-23 |
Megan Alexander
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 01-09-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Barbara Duncan
BRD | Director/Board Member | 59 | 14-06-17 |
Bart Friedman
BRD | Director/Board Member | 79 | 23-11-15 |
Jeremy Levin
CEO | Chief Executive Officer | 70 | 01-04-14 |
Karen Bernstein
BRD | Director/Board Member | 71 | 30-09-15 |
Robert Poole
BRD | Director/Board Member | 67 | 09-07-21 |
Kevin Fitzgerald
BRD | Director/Board Member | 56 | 06-10-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 70 944 627 | 59 682 851 ( 84,13 %) | 0 | 84,13 % |
Aandeel B | 0 | 1 250 | 0 | 0 |
Bedrijfsgegevens
![Adres Ovid Therapeutics Inc.(OVID)](https://cdn.zonebourse.com/static/address/34771447.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-77,87% | 50,56 mln. | |
+16,49% | 122 mld. | |
+21,73% | 115 mld. | |
+22,10% | 26,64 mld. | |
-21,81% | 19,91 mld. | |
-16,89% | 16,32 mld. | |
-18,81% | 15,49 mld. | |
-44,74% | 15,52 mld. | |
+62,72% | 14,83 mld. | |
+3,09% | 13,67 mld. |
- Beurs
- Aandelen
- Koers OVID
- Onderneming Ovid Therapeutics Inc.